This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this book Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brady, M. J. Articles by Saltiel, A. R. Search for Related Content PubMed PubMed Citation Articles by Brady, M. J. Articles by Saltiel, A. R.

The Role of Protein Phosphatase-1 in Insulin Action

Department of Cell Biology, Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road, Ann Arbor, Michigan 48105

ABSTRACT

Insulin is the most-potent physiological anabolic agent known, promoting the synthesis and storage of carbohydrates and lipids and inhibiting their degradation and release into the circulation. This action of the hormone is due in part to the acute regulation of metabolic enzymes through changes in their phosphorylation state. In fat, liver, and muscle, insulin stimulates the dephosphorylation of a number of enzymes involved in glycogen and lipid metabolism via activation of protein phosphatases. Numerous studies have indicated that protein phosphatase-1 (PP1) is the primary phosphatase involved in insulin action. Although PP1 is a cytosolic protein, the phosphatase is compartmentalized in cells by discrete targeting subunits. These proteins confer substrate specificity to PP1 and mediate the specific regulation of intracellular pools of PP1 by a variety of extracellular signals. Four proteins have been described that target the phosphatase to the glycogen particle. G_M and G_L are expressed exclusively in striated muscle and liver, while protein targeting to glycogen (PTG) and R6 are more widely expressed. Despite a common targeting function, these four proteins are not highly conserved, suggesting profound differences in the mechanisms by which they contribute to the hormonal regula- tion of PP1 activity. Overexpression studies in cell lines or animals have revealed major differences among these proteins regarding basal glycogen levels and hormonal responsiveness. Furthermore, alterations in the expression or function of PP1 glycogen-targeting subunits may contribute to the onset of insulin resistance and type 2 diabetes.

This article has been cited by other articles:

				V. S. Tagliabracci, J. M. Girard, D. Segvich, C. Meyer, J. Turnbull, X. Zhao, B. A. Minassian, A. A. DePaoli-Roach, and P. J. Roach Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease J. Biol. Chem., December 5, 2008; 283(49): 33816 - 33825. [Abstract] [Full Text] [PDF]

				S. Stamm Regulation of Alternative Splicing by Reversible Protein Phosphorylation J. Biol. Chem., January 18, 2008; 283(3): 1223 - 1227. [Abstract] [Full Text] [PDF]

				A. Cheng, M. Zhang, M. S. Gentry, C. A. Worby, J. E. Dixon, and A. R. Saltiel A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease Genes & Dev., October 1, 2007; 21(19): 2399 - 2409. [Abstract] [Full Text] [PDF]

				M. J. Jurczak, A. M. Danos, V. R. Rehrmann, M. B. Allison, C. C. Greenberg, and M. J. Brady Transgenic overexpression of protein targeting to glycogen markedly increases adipocytic glycogen storage in mice Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E952 - E963. [Abstract] [Full Text] [PDF]

				R. Zhande, W. Zhang, Y. Zheng, E. Pendleton, Y. Li, R. D. Polakiewicz, and X. J. Sun Dephosphorylation by Default, a Potential Mechanism for Regulation of Insulin Receptor Substrate-1/2, Akt, and ERK1/2 J. Biol. Chem., December 22, 2006; 281(51): 39071 - 39080. [Abstract] [Full Text] [PDF]

				A. Cheng, M. Zhang, S. M. Crosson, Z. Q. Bao, and A. R. Saltiel Regulation of the Mouse Protein Targeting to Glycogen (PTG) Promoter by the FoxA2 Forkhead Protein and by 3',5'-Cyclic Adenosine 5'-Monophosphate in H4IIE Hepatoma Cells Endocrinology, July 1, 2006; 147(7): 3606 - 3612. [Abstract] [Full Text] [PDF]

				C. C. Greenberg, M. J. Jurczak, A. M. Danos, and M. J. Brady Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E1 - E8. [Abstract] [Full Text] [PDF]

				C. Mounier, V. Dumas, and B. I. Posner Regulation of Hepatic Insulin-Like Growth Factor-Binding Protein-1 Gene Expression by Insulin: Central Role for Mammalian Target of Rapamycin Independent of Forkhead Box O Proteins Endocrinology, May 1, 2006; 147(5): 2383 - 2391. [Abstract] [Full Text] [PDF]

				C. C. Greenberg, A. M. Danos, and M. J. Brady Central Role for Protein Targeting to Glycogen in the Maintenance of Cellular Glycogen Stores in 3T3-L1 Adipocytes Mol. Cell. Biol., January 1, 2006; 26(1): 334 - 342. [Abstract] [Full Text] [PDF]

				Y.-B. Kim, O. D. Peroni, W. G. Aschenbach, Y. Minokoshi, K. Kotani, A. Zisman, C. R. Kahn, L. J. Goodyear, and B. B. Kahn Muscle-Specific Deletion of the Glut4 Glucose Transporter Alters Multiple Regulatory Steps in Glycogen Metabolism Mol. Cell. Biol., November 1, 2005; 25(21): 9713 - 9723. [Abstract] [Full Text] [PDF]

				M. S. Gentry, C. A. Worby, and J. E. Dixon From The Cover: Insights into Lafora disease: Malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin PNAS, June 14, 2005; 102(24): 8501 - 8506. [Abstract] [Full Text] [PDF]

				H. Ou, L. Yan, S. Osmanovic, C. C. Greenberg, and M. J. Brady Spatial Reorganization of Glycogen Synthase upon Activation in 3T3-L1 Adipocytes Endocrinology, January 1, 2005; 146(1): 494 - 502. [Abstract] [Full Text] [PDF]

				L. Wells, L. K. Kreppel, F. I. Comer, B. E. Wadzinski, and G. W. Hart O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits J. Biol. Chem., September 10, 2004; 279(37): 38466 - 38470. [Abstract] [Full Text] [PDF]

				N. Viguerie, K. Clement, P. Barbe, M. Courtine, A. Benis, D. Larrouy, B. Hanczar, V. Pelloux, C. Poitou, Y. Khalfallah, et al. In Vivo Epinephrine-Mediated Regulation of Gene Expression in Human Skeletal Muscle J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2000 - 2014. [Abstract] [Full Text] [PDF]

				J. F. P. Wojtaszewski, J. N. Nielsen, and E. A. Richter Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Effect of acute exercise on insulin signaling and action in humans J Appl Physiol, July 1, 2002; 93(1): 384 - 392. [Abstract] [Full Text] [PDF]

				J. N. Nielsen, J. Vissing, J. F. P. Wojtaszewski, R. G. Haller, N. Begum, and E. A. Richter Decreased insulin action in skeletal muscle from patients with McArdle's disease Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1267 - E1275. [Abstract] [Full Text] [PDF]